my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Addex Pharmaceuticals announced that its scientists have demonstrated that, in the presence of GLP-1, glucagon-like-peptide-1 receptor (GLP1R) can form a heterodimer receptor complex with gastric-inhibitory-peptide-receptor (GIPR). The discovery of this novel interaction between the two G-protein-co more
Addex Pharmaceuticals announced that it will regain all rights to its metabotropic glutamate receptor 4 (mGluR4) positive allosteric modulator (PAM) program from Merck, known as MSD outside the United States and Canada, due to further pipeline prioritization."We continue to strongly believe that mGl more
Addex Pharmaceuticals announced changes to the Company's Board of Directors. Vincent Lawton, an existing director at Addex, has been appointed Vice-Chairman. In addition, Vincent Mutel formally resigned his position as Member of the Board of Directors of Addex. As previously announced, Dr. Mutel st more
Treatment frontiers Nature 467, 622 (2010). doi:10.1038/nature09476 Author: Kerri Smith Nature466 (suppl.), S15–S18 (10.1038/466S15a26 August 2010)This Outlook article stated that Addex Pharmaceuticals has mGluR5 modulators in phase II trials for anxiety and depression. The company says th more
FAQs Brochure Home Latest News! NiKem Research Receives Authorization for Rodent Toxicology Studies (May 3rd, 2010) NiKem Research is pleased to announce that it has received on March 29th 2010, from the Italian Ministry of Health (Decree N. 69/2010-B), the authorization to perform acute and sub-chr more
Syntaxin's Board of Directors Biotechnology Company About Syntaxin Biopharmaceutical Product Pipeline Biotech Research & Development Bio Tech News Contact Biopharmaceutical Firm Biotech Company About Us History Board of Directors Management Team Investors Scientific Advisory Board ddsdas Syntaxin's more
For Immediate Release NiKem Research Srl Enters Into an Extensive Research Service Agreement with Addex Pharmaceuticals S.A. Milan — February 11th, 2005— NiKem Research Srl announced today that it has entered into a new Research Agreement with Addex Pharmaceuticals S.A. Under the terms of the agr more
Watchlist
This is where you can add this topic to your personal favourites
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
